Viewing StudyNCT00453570



Ignite Creation Date: 2024-05-05 @ 5:26 PM
Last Modification Date: 2024-10-26 @ 9:31 AM
Study NCT ID: NCT00453570
Status: COMPLETED
Last Update Posted: 2012-04-17
First Post: 2007-03-28

Brief Title: Immunogenicity and Safety of Pentaxim as 3 Doses Primary Vaccination Followed by a Booster Dose at 18 Months
Sponsor: Sanofi
Organization: Sanofi

Conditions & Keywords Data

Conditions:
Name
Diphtheria
Tetanus
Haemophilus Influenzae Type b
Pertussis
Poliomyelitis
Keywords:
Name View
Pertussis View
Diphteria View
Tetanus View
Haemophilus influenzae type b View
Poliomyelitis View